About Dr Martin Schiele
Dr. Martin Schiele, a biomedical research scientist, and his team have many years experience in immunology and dermatology. All the skills, expertise and experience gained have given a thorough foundation and know-how to develop and formulate products consisting only of natural substances for the treatment of major skin disorders.

Dr. Schiele was also involved in research and consultancy work for medical high schools, universities and international corporations as well as health ministries. As a result, many publications have appeared in peer review magazines and papers, such as the Journal of Clinical Chemistry and Clinical Biochemistry, Oxford University Press, Laboratory News, Advances in Medicine, Clinical Laboratory International, Management Journal for Occupational Health, Safety and Environment, Today’s Therapist, Health Director, National Association of Primary Care “Review Book”, Whole Health Journal and the Alternative Magazine.

Furthermore, at international medical congresses, Dr. Schiele and his team were invited to give presentations on their completed research work as it represented major advances in the diagnosis, prevention and treatment of major health and skin problems.

Dr. Schiele was invited to the IPI (Institute of Pharmaceutical Innovation) at the Royal Society and the House of Lords to show case his capabilities and latest developments. Although Dr. Schiele is not developing pharmaceutical products, the event also focused on natural biotechnology and bioscience and was of high importance.

Dr. Schiele was also invited to the Medica Exhibition and Congress, Germany, to demonstrate newly developed therapeutic products to a worldwide audience. MEDICA is the worlds largest congress for medicine and is the key event for the health care technologies sector to showcase and pick up on the latest developments in out and in-patient healthcare.


Health Matters by Carole Kaplin - Mail on Sunday 23rd March 2008The Mail on Sunday

Carole Caplin – Living Matters - 23rd March 2008 [extract]

Are these skin creams doing more harm than good?

Whether it be an incipient spot, a flaky patch or full blown eczema, we all tend to deal with rebellious skin by smothering it with moisturizer or ‘medicated’ cream, oblivious to the fact that the substances we are applying to get rid of the problem may actually be making it worse.

Despite ‘new and improved’ products, I think the bad stuff is hard to avoid. Whether you buy moisturizer from a high-end ‘derma cosmetic boutique’, a High Street chemist or supermarket, there’s a good chance it will contain three commonly used additives. Parabens are relatives of benzoic acid, created synthetically, widely as preservatives and thought to be carcinogenic.

Then there’s propylene glycol, also used in anti-freeze and brake fluid. Its official safety sheet warns against skin contact because of strong irritation and possible kidney and liver damage.

And lastly sodium laureth sulphate (SLS), used commercially to remove grease from car engines and as an industrial cleaner. It removes moisture from skin and causes skin irritation.

The body absorbs up to 60 per cent of the chemicals we put on our skins, and some doctors and dermatologists are convinced that the increase in skin complaints is the result of so-called ‘skin sensitisers’ in all the cosmetics and medications used to alleviate them.

These include emollient moisturisers used to treat eczema which contains methyl hydroxybenzoate, the most commonly used paraben in skin products.

Dr. Martin Schiele, a bio medical research scientist, has formulated Salcura nutrient-based skin therapy products that strengthen the skin’s own healing properties. Ingredients include vitamins, amino acids, minerals, essential oils and omegas 3, 6, 7 & 9 – the very properties damaged by the steroids and suppressive pharmaceuticals found in most commonly prescribed skin treatments.

Most of us now acknowledge that many additives used to preserve food can cause behavioral and metabolic problems. I am sure we will become just as aware of the damage our skin may suffer from the preservatives and stabilizers to be found in the moisturisers and creams we have been using to nourish heal and protect it.


NEW SUCCESSFUL TREATMENTS FOR SKIN DISORDERS WITH CLASS 1 MEDICAL DEVICES
NAPC Sring 2008Bioscience can offer a more practical, long term effective and cost saving alternative in the prevention and management of skin conditions latex allergy types | & lV and also HAI (MRSA) skin infections. One of the latest range of natural skin management based on innovative science and applying biotechnology/nano technology is Salcura Natural Skin Therapy (Class 1 Medical Devices). Salcura is free from steroids, antibiotics, alcohol, parabens, and can be used long term effectively with no known side effects.

A recent benchmark study undertaken by the University of Leeds, School of Medicine and the Universitoyf Bradford, Research and Knowledge Transfer Support confirms that Salcura oroducts are the only "Natural Colloidal Solution Deliver System" on the market for skin allergies/disorders/infections and wound care.


skincare reportsArticle from the National Association of Primary Care Spring Review 2008 NEW SUCCESSFUL TREATMENTS FOR SKIN DISORDERS WITH CLASS 1 MEDICAL DEVICES (Salcura Professional Skin Management) read more...


A new look at nutrients based skin treatments
Dr Martin Schiele explains the importance of nutrients based (phtyotheraputic) formulations for the treatment and management of skin disorders, and the overall benefits provided by vitamins, minerals and essential oils to skin health.
The Pharmacist Winter 2007The body when healthy maintains a state of balance or equilibrium in which all systems including the skin, OTC Medicines Advice function smoothly. Deficiencies of vital nutrients are linked to poor immune function leading to poor skin health. Bioscience can offer a natural approach by carefully formulating natural colloidal solutions consisting of vital nutrients to activate homeostasis efficiently and effectively case studies of such successful treatments have been published by the National Association of Primary Care(NAPC).

skincare reportsArticle from The Pharmacist Winter 2007 explaining the importance of nutrients based (phytotheraputic) formulations for the treatment and management of skin disorders, and the overall benefits provided by vitamins, minerals, and essential oils to skin health. read more...


IPI logoStands for Innovative Science

Only ten companies had been invited to actively demonstrate and explain their research and development capabilities and achievements. Salcura Ltd was one of these.

The opening address was held by Lord David Sainsbury of Turville, Parliamentary under-secretary of state for science and innovation and the welcoming address was by Baroness Lockwood.

The audience comprised of the following:

  • Chief Executives, Research Directors and Senior Regulatory Officers from multinational and other large pharmaceutical companies.

  • Chief Executives of overseas companies seeking to develop drug candidates in European markets (anticipated in-bound trade missions from US and Japan)

  • Senior Executives from partners in NHS, DTI, UKTI, Department of Health and other senior home and overseas Government officials

  • Senior representatives from funding organisations


Delegates: Expected attendance between 175 to 200 persons - The list of guests included:

  • ABPI (Association of the British Pharmaceutical Industry)
  • AstraZeneca
  • Avecia Pharmaceuticals
  • Avlar BioVentures
  • BBSRC (Biotechnology and Biological Sciences Research Council)
  • Belgian Embassy
  • Bionet
  • Bradford Royal Infirmary
  • Bristol-Myers Squibb
  • Canadian High Commission
  • Celltech Group
  • City of Bradford Metropolitan District Council
  • De Novo Pharmaceuticals
  • Department of Health
  • DTI (Department of Trade and Industry)
  • Embassy of Mexico
  • Embassy of the People's Republic of China
  • Embassy of the United States of America
  • EPSRC (Engineering and Physical Sciences Research Council)
  • Femcare
  • Guyana High Commission
  • Health Select Committee, House of Commons
  • High Commission of India
  • High Commission for the United Republic of Tanzania
  • Hong Kong Economic and Trade Office
  • Indonesian Embassy
  • Italian Embassy
  • Kowa Research Europe Ltd
  • Learning and Skills Council for West Yorkshire
  • Medicines and Healthcare products Regulatory Agency
  • Medilink (Yorkshire & Humber)
  • Members of the House of Commons
  • Members of the House of Lords
  • Members of University of Bradford Council
  • Merck Sharp & Dohme
  • Napp Pharmaceuticals Research
  • Nations Healthcare
  • Nektar Therapeutics
  • NHS Innovations
  • Office of Science and Technology
  • Pfizer
  • Quintiles Scotland
  • Royal Danish Embassy
  • Royal Pharmaceutical Society of Great Britain
  • Serono International SA
  • Shire Pharmaceuticals
  • Science and Technology Select Committee, House of Commons
  • St Luke's Woodside Hospital, London
  • Tripoli Medical Centre
  • Uhde High Pressure Technologies GmbH
  • University of Basel
  • University of Bradford
  • University of Helsinki
  • Wyeth
  • Yorkshire Forward

napc  review book

UK National Association of Primary Care - the NAPC Review Book autumn edition.

The NAPC - Review Book editorials, written by Dr Schiele resulted in a surge of telephone enquiries (from pharmacies and general practitioners) and in conclusion has accelerated the interest of professionals within the NHS.

This is the official information source for general practitioners, senior practice nurses, primary care groups and trusts, health authorities and NHS executives. (Approx. readership 50,000)

Two editions of the NAPC - Review have included two major editorial features on different topical features on Dermatology.

skincare reportsArticle from the National Association of Primary Care Winter Review 2004/5 The case for a non pharmaceutical approach to treating skin disorders read more...


Dr Martin Schiele had been invited to contribute with two editorials to this publication on the subjects:

THE CASE FOR A NON-PHARMACEUTICAL APPROACH TO TREATING COMMON SKIN DISORDERS. (EDITORIAL)

SKIN ALLERGIES / DISORDERS IN THE 21ST CENTURY (EDITORIAL)

Dr Martin Schieleand his team had also been invited to submit a product profile and information on the whole range of products, which was printed in this review book.
Furthermore, they were also asked to submit our corporate profile for publication on the official website of the National Association of Primary Care (live for viewing)

About the NAPC - Review.

NAPC reviewTHE NAPC REVIEW is an official title of the National Association of Primary Care (NAPC). This unique publication provides health sector management with all they need to know about the new primary care led National Health Service and reviews the most vital issues facing the health sector and the NHS today.

THE NAPC REVIEW is a major platform of communication and forms an important part of the Association's ongoing work in informing, exchanging ideas and uniting medical experts in order to raise the standard of healthcare in the UK. The book is specifically designed to provide decision makers within the profession with relevant information on the latest developments in clinical care, medical supplies and equipment, pharmaceutical supplies and management and education issues.

skincare reportsArticle from the National Association of Primary Care Review 2005 - Skin allergies / disorders in the 21st Century read more...

 

The NAPC represents and negotiates Primary Care Group's interests with central Government and other political parties. In addition to working with the NHS Executive, the Secretary of State and the Chief Medical Officer, members' interests are represented on many national working groups, which create opportunities for creating and shaping policies.

Dr Schiele's comments: It is nice to know that other medical experts, besides ourselves believe my team and I can raise the standards of healthcare for the patients benefit in the UK.